Mirror Medacta Shoulder System Pivotal Trial

NCT ID: NCT05062252

Last Updated: 2025-05-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-05

Study Completion Date

2027-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to demonstrate safety and efficacy of the Mirror Medacta Shoulder System in total shoulder arthroplasty.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arthritis Shoulder Post-traumatic Arthrosis of Other Joints, Upper Arm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mirror group

Mirror Medacta Shoulder System

Group Type EXPERIMENTAL

Mirror Medacta Shoulder System

Intervention Type DEVICE

Anatomic total shoulder arthroplasty system

Historical Control group

Total shoulder arthroplasty system

Group Type ACTIVE_COMPARATOR

Medacta Shoulder System

Intervention Type DEVICE

Anatomic total shoulder arthroplasty system - standard configuration

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mirror Medacta Shoulder System

Anatomic total shoulder arthroplasty system

Intervention Type DEVICE

Medacta Shoulder System

Anatomic total shoulder arthroplasty system - standard configuration

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 yr
* Clinical indication for anatomic primary total shoulder replacement due to osteoarthritis and/or posttraumatic arthritis
* Willingness and ability to comply with study protocol

Exclusion Criteria

* Medical condition or balance impairment that could lead to falls
* Prior rotator cuff surgery
* Cuff tear arthropathy/insufficient rotator cuff
* Insufficient bone quality which may affect the stability of the implant
* Neuromuscular compromise of shoulder or other disabilities affecting the maximum functional outcomes
* Weight bearing shoulder due to wheel chair, crutches, rollator at the time of operation
* Active metastatic or neoplastic disease at the shoulder joint
* Chemotherapy treatment/radiotherapy within 6 mo before surgery
* \>5 mg/day of corticosteroids, excluding inhalers, within 3 years before surgery
* Pregnancy or plan to become pregnant during study period
* Inability to understand study or a history of noncompliance with medical advice
* Alcohol or drug abuse
* Current enrollment in any clinical research study that might interfere with this study
* Metal allergies or sensitivity.
* Previous or current infection at or near the site of implantation.
* Current distant or systemic infection
* Patient, whose infomed consent form should be taken in an emergency situation
* ONLY for women of childbearing age: a positive pregnancy test (urine / blood)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medacta International SA

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Matthias A Zumstein, Prof Dr. med

Role: PRINCIPAL_INVESTIGATOR

Lindenhofgruppe AG (Bern)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lindenhofgruppe AG - Orthopädie Sonnenhof

Bern, , Switzerland

Site Status RECRUITING

Klinik für Orthopädische Chirurgie und Traumatologie des Bewegungsapparates, Kantonsspital St.Gallen

Sankt Gallen, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marco Viganò, PhD

Role: CONTACT

+41 091 6966060

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Annabel Hayoz

Role: primary

Vilijam Zdravkovic, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P06.003.01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Reverse Shoulder Prosthesis Study
NCT00764504 COMPLETED PHASE3
Anatomical Shoulder Domelock System Study
NCT03312465 ACTIVE_NOT_RECRUITING
Comprehensive Reverse Shoulder Data Collection
NCT03404778 ENROLLING_BY_INVITATION
AETOS Shoulder System
NCT06319911 RECRUITING